KRT17 and neoplasm: Regarding CK5, Dairkee and colleagues reported for the first time the possible poor survival or early recurrence associated with the expression of CK5 in tumor cells in 1987 [43] and, although the functional role of the CK, such as CK5, CK14, or CK17, is still unknown, their expression is clearly associated with poor prognosis.